EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Coronavirus disease 2019-induced acute kidney injury: a retrospective single-center study

Adel T Abd Elhadi, Marwa M. Allahouny, Ahmed A. Elesdoudy, Nivart F.F. Shenouda

The Egyptian Journal of Chest Diseases and Tuberculosis · 2026-04 · 75 (2) · 198-203

DOI: 10.4103/ecdt.ecdt_72_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Egyptian Journal of Chest Diseases and Tuberculosis, online erschienen am 08.04.2026. Verfasst von Adel T Abd Elhadi und 3 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute kidney injury (AKI) is a frequent complication in patients with severe coronavirus disease 2019 (COVID-19), contributing to increased mortality and longer hospital stays. This study investigates the effects of tocilizumab (TCZ) on renal function in such patients. Patients and methods A retrospective analysis was conducted on 250 patients with confirmed severe COVID-19. Daily monitoring of renal indicators was performed. Those with suspected cytokine storm—indicated by raised interleukin-6 or C-reactive protein levels greater than 75 mg/l—received TCZ at 4–8 mg/kg (up to 800 mg), either once or in repeated doses.

Results

Renal impairment and electrolyte disturbances were significant after admission ( P =0.001). AKI developed in 52% of patients, and 8% required continuous renal replacement therapy. Urine analysis revealed hematuria in 10%, proteinuria in 28%, and normal findings in 62%. Comorbidities included diabetes and hypertension (each in 40% of patients), CKD (16%), ischemic heart disease (14%), asthma (6%), and hypothyroidism (4%). TCZ administration led to marked improvement in renal parameters and electrolytes ( P =0.001).

Conclusion

AKI is common in severe COVID-19 cases and may signal worse outcomes. Routine monitoring of kidney function is crucial. TCZ may offer indirect renal protection in COVID-19-associated AKI, especially when used early in cytokine storm.

Zitieren

APA

Elhadi, A. T. A., Allahouny, M. M., Elesdoudy, A. A., & Shenouda, N. F. (2026). Coronavirus disease 2019-induced acute kidney injury: a retrospective single-center study. The Egyptian Journal of Chest Diseases and Tuberculosis, 75(2), 198-203. https://doi.org/10.4103/ecdt.ecdt_72_25

Vancouver

Elhadi ATA, Allahouny MM, Elesdoudy AA, Shenouda NF. Coronavirus disease 2019-induced acute kidney injury: a retrospective single-center study. The Egyptian Journal of Chest Diseases and Tuberculosis. 2026;75(2):198-203. doi:10.4103/ecdt.ecdt_72_25

BibTeX
@article{Elhadi2026,
  author = {Elhadi, Adel T Abd and Allahouny, Marwa M. and Elesdoudy, Ahmed A. and Shenouda, Nivart F.F.},
  title = {Coronavirus disease 2019-induced acute kidney injury: a retrospective single-center study},
  journal = {The Egyptian Journal of Chest Diseases and Tuberculosis},
  year = {2026},
  volume = {75},
  number = {2},
  pages = {198--203},
  doi = {10.4103/ecdt.ecdt_72_25}
}
Kostenlos starten →